Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age

Background: Infants are at the highest risk for meningococcal disease and a broadly protective and safe vaccine is an unmet need in this youngest population. We evaluated the immunogenicity and safety of a 4-dose infant/toddler regimen of MenACWY-CRM given at 2, 4, 6, and 12 months of age concomitan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nolan, Terry M, Nissen, Michael D, Naz, Aftab, Shepard, Julie, Bedell, Lisa, Hohenboken, Matthew, Odrljin, Tatjana, Dull, Peter M
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185919/
https://ncbi.nlm.nih.gov/pubmed/24220326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados